Amnis Corporation

Biotechnology ResearchWashington, United States11-50 Employees

Amnis developed the ImageStream and FlowSight imaging flow cytometry platforms. These systems simultaneously produce 12 high resolution images of each cell directly in fluid flow, at rates up to 5,000 cells per second, and with fluorescence sensitivity that exceeds traditional microscopy or flow cytometry. Amnis' imaging technology is protected by more than 50 issued US and international patents. The company was founded in 1999 and was acquired in 2011 by EMD Millipore, a division of Merck KGaA, for $110 million.

Sign up for free to view info

Email Format Employee directory